These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 15544433)

  • 1. Metabonomics: its potential as a tool in toxicology for safety assessment and data integration.
    Griffin JL; Bollard ME
    Curr Drug Metab; 2004 Oct; 5(5):389-98. PubMed ID: 15544433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies.
    Aardema MJ; MacGregor JT
    Mutat Res; 2002 Jan; 499(1):13-25. PubMed ID: 11804602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic profiling as a tool for understanding mechanisms of toxicity.
    Clarke CJ; Haselden JN
    Toxicol Pathol; 2008 Jan; 36(1):140-7. PubMed ID: 18337232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twenty years of metabonomics: so what has metabonomics done for toxicology?
    Griffin JL
    Xenobiotica; 2020 Jan; 50(1):110-114. PubMed ID: 31826699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach.
    Ebbels TM; Keun HC; Beckonert OP; Bollard ME; Lindon JC; Holmes E; Nicholson JK
    J Proteome Res; 2007 Nov; 6(11):4407-22. PubMed ID: 17915905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabonomics techniques and applications to pharmaceutical research & development.
    Lindon JC; Holmes E; Nicholson JK
    Pharm Res; 2006 Jun; 23(6):1075-88. PubMed ID: 16715371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EU framework 6 project: predictive toxicology (PredTox)--overview and outcome.
    Suter L; Schroeder S; Meyer K; Gautier JC; Amberg A; Wendt M; Gmuender H; Mally A; Boitier E; Ellinger-Ziegelbauer H; Matheis K; Pfannkuch F
    Toxicol Appl Pharmacol; 2011 Apr; 252(2):73-84. PubMed ID: 20955723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project.
    Lindon JC; Nicholson JK; Holmes E; Antti H; Bollard ME; Keun H; Beckonert O; Ebbels TM; Reily MD; Robertson D; Stevens GJ; Luke P; Breau AP; Cantor GH; Bible RH; Niederhauser U; Senn H; Schlotterbeck G; Sidelmann UG; Laursen SM; Tymiak A; Car BD; Lehman-McKeeman L; Colet JM; Loukaci A; Thomas C
    Toxicol Appl Pharmacol; 2003 Mar; 187(3):137-46. PubMed ID: 12662897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent development of metabonomics and its applications in clinical research].
    Li H; Jiang Y; He FC
    Yi Chuan; 2008 Apr; 30(4):389-99. PubMed ID: 18424407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabonomics for discovering biomarkers of hepatotoxicity and nephrotoxicity.
    Zhang A; Sun H; Wang P; Han Y; Wang X
    Pharmazie; 2012 Feb; 67(2):99-105. PubMed ID: 22512077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Metabonomics Approach to Drug Toxicology in Liver Disease and its Application in Traditional Chinese Medicine.
    Su G; Wang H; Bai J; Chen G; Pei Y
    Curr Drug Metab; 2019; 20(4):292-300. PubMed ID: 30599107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of metabonomics in drug development.
    Keun HC; Athersuch TJ
    Pharmacogenomics; 2007 Jul; 8(7):731-41. PubMed ID: 18240906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabonomics in pharmaceutical R&D.
    Lindon JC; Holmes E; Nicholson JK
    FEBS J; 2007 Mar; 274(5):1140-51. PubMed ID: 17298438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology.
    Coen M; Holmes E; Lindon JC; Nicholson JK
    Chem Res Toxicol; 2008 Jan; 21(1):9-27. PubMed ID: 18171018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR-based metabolomics.
    Reo NV
    Drug Chem Toxicol; 2002 Nov; 25(4):375-82. PubMed ID: 12378948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabonomic modeling of drug toxicity.
    Keun HC
    Pharmacol Ther; 2006 Jan; 109(1-2):92-106. PubMed ID: 16051371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemometric contributions to the evolution of metabonomics: mathematical solutions to characterising and interpreting complex biological NMR spectra.
    Holmes E; Antti H
    Analyst; 2002 Dec; 127(12):1549-57. PubMed ID: 12537357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein biomarkers for in vitro testing of toxicology.
    Schrattenholz A; Šoškić V; Schöpf R; Poznanović S; Klemm-Manns M; Groebe K
    Mutat Res; 2012 Aug; 746(2):113-23. PubMed ID: 22405942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of metabonomics at the interface between drug metabolism and safety assessment.
    Waters NJ
    Curr Drug Metab; 2010 Oct; 11(8):686-92. PubMed ID: 20973758
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.